Sotnikova Tatyana D, Budygin Evgeny A, Jones Sara R, Dykstra Linda A, Caron Marc G, Gainetdinov Raul R
Howard Hughes Medical Institute, Department of Cell Biology and Medicine, and Center for Models of Human Disease, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Neurochem. 2004 Oct;91(2):362-73. doi: 10.1111/j.1471-4159.2004.02721.x.
Beta-phenylethylamine (beta-PEA) is an endogenous amine that is found in trace amounts in the brain. It is believed that the locomotor-stimulating action of beta-PEA, much like amphetamine, depends on its ability to increase extracellular dopamine (DA) concentrations owing to reversal of the direction of dopamine transporter (DAT)-mediated DA transport. beta-PEA can also bind directly to the recently identified G protein-coupled receptors, but the physiological significance of this interaction is unclear. To assess the mechanism by which beta-PEA mediates its effects, we compared the neurochemical and behavioral effects of this amine in wild type (WT), heterozygous and 'null' DAT mutant mice. In microdialysis studies, beta-PEA, administered either systemically or locally via intrastriatal infusion, produced a pronounced outflow of striatal DA in WT mice whereas no increase was detected in mice lacking the DAT (DAT-KO mice). Similarly, in fast-scan voltammetry studies beta-PEA did not alter DA release and clearance rate in striatal slices from DAT-KO mice. In behavioral studies beta-PEA produced a robust but transient increase in locomotor activity in WT and heterozygous mice. In DAT-KO mice, whose locomotor activity and stereotypy are increased in a novel environment, beta-PEA (10-100 mg/kg) exerted a potent inhibitory action. At high doses, beta-PEA induced stereotypies in WT and heterozygous mice; some manifestations of stereotypy were also observed in the DAT-KO mice. These data demonstrate that the DAT is required for the striatal DA-releasing and hyperlocomotor actions of beta-PEA. The inhibitory action on hyperactivity and certain stereotypies induced by beta-PEA in DAT-KO mice indicate that targets other than the DAT are responsible for these effects.
β-苯乙胺(β-PEA)是一种内源性胺类物质,在大脑中含量微量。据信,β-PEA的运动刺激作用与安非他命类似,依赖于其通过逆转多巴胺转运体(DAT)介导的多巴胺(DA)转运方向来增加细胞外多巴胺浓度的能力。β-PEA还可直接结合最近发现的G蛋白偶联受体,但其这种相互作用的生理意义尚不清楚。为评估β-PEA介导其作用的机制,我们比较了该胺类物质在野生型(WT)、杂合型和“无”DAT突变小鼠中的神经化学和行为效应。在微透析研究中,全身给药或通过纹状体内注射局部给予β-PEA,可使WT小鼠纹状体DA显著外流,而在缺乏DAT的小鼠(DAT-KO小鼠)中未检测到增加。同样,在快速扫描伏安法研究中,β-PEA未改变DAT-KO小鼠纹状体切片中DA的释放和清除率。在行为学研究中,β-PEA使WT和杂合型小鼠的运动活性出现强烈但短暂的增加。在新环境中运动活性和刻板行为增加的DAT-KO小鼠中,β-PEA(10 - 100 mg/kg)发挥了强大的抑制作用。高剂量时,β-PEA在WT和杂合型小鼠中诱导刻板行为;在DAT-KO小鼠中也观察到了一些刻板行为表现。这些数据表明,DAT是β-PEA纹状体DA释放和运动亢进作用所必需的。β-PEA对DAT-KO小鼠多动和某些刻板行为的抑制作用表明,除DAT外的其他靶点介导了这些效应。